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Abstract
Background: Zinc treatment of childhood diarrhea has the potential to save 400,000 under-five lives per year in lesser
developed countries. In 2004 the World Health Organization (WHO)/UNICEF revised their clinical management of childhood
diarrhea guidelines to include zinc. The aim of this study was to monitor the impact of the first national campaign to scale
up zinc treatment of childhood diarrhea in Bangladesh.
Methods/Findings: Between September 2006 to October 2008 seven repeated ecologic surveys were carried out in four
representative population strata: mega-city urban slum and urban nonslum, municipal, and rural. Households of
approximately 3,200 children with an active or recent case of diarrhea were enrolled in each survey round. Caretaker
awareness of zinc as a treatment for childhood diarrhea by 10 mo following the mass media launch was attained in 90%,
74%, 66%, and 50% of urban nonslum, municipal, urban slum, and rural populations, respectively. By 23 mo into the
campaign, approximately 25% of urban nonslum, 20% of municipal and urban slum, and 10% of rural under-five children
were receiving zinc for the treatment of diarrhea. The scale-up campaign had no adverse effect on the use of oral
rehydration salt (ORS).
Conclusions: Long-term monitoring of scale-up programs identifies important gaps in coverage and provides the
information necessary to document that intended outcomes are being attained and unintended consequences avoided.
The scale-up of zinc treatment of childhood diarrhea rapidly attained widespread awareness, but actual use has lagged
behind. Disparities in zinc coverage favoring higher income, urban households were identified, but these were gradually
diminished over the two years of follow-up monitoring. The scale up campaign has not had any adverse effect on the use of
ORS.
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About 1.9 million children under the age of 5 y annually die
from diarrhea, accounting for 19% of all under-five mortality [1].
Clinical trials of zinc treatment in children 6 mo to 5 y of age have
consistently demonstrated its ability to reduce disease duration and
severity as well as the likelihood of a repeat episode [2–4]. It has
been estimated that the successful scaling up of zinc treatment for
childhood diarrhea could potentially save 400,000 under-five
deaths per year [5]. In response to the curative and preventive
evidence in support of zinc treatment, in 2004 WHO/UNICEF
revised their clinical management of childhood diarrhea guidelines
to include zinc treatment of any episode [6]. The present challenge
is the scale up of zinc treatment and other life-saving interventions
within resource-deprived health systems with limited capacity to
absorb additional services. As has been pointed out by others,
efforts to bring zinc treatment to scale have the potential to
significantly benefit children, but may also have harmful
consequences through their impact on other health behaviours
or services [7,8].
The Scaling Up of Zinc for Young Children (SUZY) Project
was established in 2003 with the aim of setting Bangladesh on the
path to covering all under-five children with zinc treatment of any
diarrheal illness episode. A partnership was created that included
public, private, nongovernmental organisation, and multinational
sector agencies. Over a period of 3 y activities in support of
preparing for the national scale up included formative and
operational research, product registration and technology transfer,
awareness building and orientation of health professionals, and
preparation of mass media messages. In December, 2006 a
national mass media campaign to promote a dispersible tablet zinc
formulation, ‘‘Baby Zinc,’’ for the treatment of childhood diarrhea
was launched. All media messages linked zinc treatment to the
continued use of oral rehydration salts (ORS).
In order to monitor the success of the project in achieving its
intended aims, as well as other unintended consequences,
continuous nationally representative zinc coverage surveys have
been carried out in Bangladesh that coincide with the national
launch of a mass media zinc treatment promotion campaign. This
article describes the results of the national scale-up campaign over
the initial 2 y of its conduct. The primary outcomes of interest
were the documentation of the proportion of children receiving
zinc treatment for a diarrheal illness, identifying disparities in zinc
coverage, and monitoring for potential unintended outcomes, in
particular decreased use of ORS.
Methods
This study was reviewed and approved by the Research Review
and Ethical Review Committees of the International Centre for
Diarrhoeal Disease Research, Bangladesh (ICDDR,B). Given the
high levels of suspicion created when asked to sign a document
they cannot read and the minimal potential for harm, the Ethics
Review Committee of ICDDR,B approved an informed verbal
consent. A verbal consent was obtained from all participating
interviewees, with the interviewer required to sign that consent
when obtained (Text S2).
Study Design
Repeat ecologic surveys were carried out in four representative
population strata: urban Dhaka (mega-city) slum and nonslum,
municipal (small city), and rural. Prior to the launch of the planned
mass media campaign a baseline survey was completed between
September and November 2006. Thereafter, postlaunch surveys
were repeated over the following dates; 12/2006 to 02/2007
(1–3 mo), 03 to 05/2007 (4–6 mo), 06 to 09/2007 (7–10 mo),
10/2007 to 01/2008 (11–14 mo), 02 to 05/2008 (15–18 mo), and
06 to 10/2008 (19–23 mo).
Population
Source population. There are two large ‘‘mega-cities’’ in
Bangladesh, one of which, Dhaka, was arbitrarily chosen (Figure 1).
In Dhaka all districts were stratified as either predominantly urban
slum or nonslum populations and two districts from each category
were randomly selected. Rural subdistricts were purposively
selected on the basis of their proximity to ICDDR,B field sites in
the west (Abhonagar), southeast (Mirsarai), and northeast
(Hobiganj) of Bangladesh. The municipal district capitals
representing each rural site were also selected (Khuna, Camila,
and Sylhet). The under-five population of these ten sites is
approximately 1.5 million children.
Study population. Within the selected sites, all wards
(defined as urban census tracts or an administrative grouping of
two to three villages) were listed and 20 randomly selected prior to
the start of each survey round. Standard WHO EPI (Expanded
Program for Immunization) cluster methods were applied [9].
These methods eliminate the need to enumerate and then
randomly select households. In rural settings a site central to the
village was chosen and a wheel board spun to determine the
direction of households to be visited following a more or less
straight line. Upon reaching the peripheral boundary of the village
the interviewers returned to the central point and spun the wheel
again. Within urban wards a central starting point was chosen and
then a systematic, door-to-door survey of households was carried
out. Within each rural or urban ward the survey was stopped once
16 children, 6–59 mo of age with an active or recent (within the
past 2 wk) episode of diarrhea of at least 48-h duration had been
identified, and informed verbal consent from either parent
obtained. If more than one child in the household was eligible,
one was randomly chosen.
Sample size estimation. Setting the level of confidence at
0.95 and a minimal detectable error of 0.05 around a prevalence
estimate, assuming the overall prevalence of zinc use to be 0.20
and adjusting by 2.5 for design effect (DE), a minimum of 615
cases per population strata were estimated to be required. The
DE~ 1zroh k{1 ðÞ ½  , where roh (rate of homogeneity) was
estimated to be 0.10 and k was arbitrarily set at 16 participants
per cluster [9]. The choice of 16 individuals per cluster represents
a compromise between data collection efficiency (larger number of
participants per cluster) and reducing the DE (smaller number of
participants per cluster). Piloting indicated that our research team
could, on average, collect 16 cases in a day, but this would vary by
time of year and the occurrence of diarrhea outbreaks.
Zinc Treatment Scale Up
Under the title ‘‘Scaling Up Zinc for Young Children (SUZY)
Project,’’ preparations and the eventual implementation of a
national campaign in support of zinc treatment for childhood
diarrhea was carried out over a period of 3 y (2003–2006). The
campaign targeted children 6 mo to 5 y of age. This was a
national effort, involving several public and private agencies, with
coordination and financial support provided through the SUZY
Project. There were no parallel campaigns occurring. Within the
Bangladesh Ministry of Health and Family Welfare (MOHFW), a
National Advisory Committee (NAC), chaired by the Health
Secretary, was created. This committee was represented by the
primary health care division of the MOHFW, the Bangladesh
Pediatric Association, and country representatives from WHO and
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specific recommendations to the NAC, including a zinc treatment
policy statement, over-the-counter and advertising permits, and
private sector participation. Private sector involvement included
the selection of a pharmaceutical laboratory to produce and
distribute a dispersible zinc tablet formulation, a marketing
agency, and private provider groups, such as the Bangladesh
Pediatric Association and the Bangladesh Village Doctors
Association. Inclusion of these professional associations was critical
given considerable doubt existed in the beginning about zinc safety
and over-the-counter sales.
Following the selection of a pharmaceutical laboratory (ACME
Pharmaceuticals, Ltd) a technology transfer from the French
nutrition firm holding the patent for the dispersible zinc
formulation (Nutriset Ltd) was arranged and eventually completed.
Following the technology transfer, this included yearly scheduled
quality control visits. ACME Pharmaceuticals then applied and
obtained from the MOHFW Drug Administration for the
following in the sequence listed: approval of the dispersible zinc
tablet formulation, brand name (Baby Zinc) and packaging design,
pricing (18 taka or approximately US$0.25 for a ten-tablet blister
pack), an over-the-counter waiver, and a permit to advertise
nationally on TV and radio.
Prior to initiating the national scale up several gaps in
knowledge were identified and protocols prepared to provide the
needed information. These included: (1) a phase IV safety and side
effects studies carried out among children attending the ICDDR,B
Dhaka hospital [10,11]; (2) formative studies to better understand
household diarrhea management decisions, treatment recommen-
dations made by providers, the influence of drug salesmen, and
knowledge of zinc and other micronutrients; (3) the acceptability of
the dispersible tablets and adherence to preparation instructions
[12]; and (4) a national survey in rural, urban slum, and nonslum
populations to determine current childhood diarrhea management
practices, health seeking behaviours, and expenditures [13]. These
studies enabled us to reassure stakeholders that zinc treatment is
safe, but associated with a low risk of nausea and vomiting. The
results from the formative studies guided the preparation of
messages for caregivers and providers. On the basis of these
interviews and focus group discussions we created a frequently
asked questions data bank and a uniform set of responses (available
at www.icddrb.org). From the surveys we learned that over 90% of
parents sought help from private sector providers and over 70% of
the time it was with an unregulated provider (village doctor or
drug vendor). It was this information that led to the decision to
focus the campaign on caretaker decision making and availability
of the zinc tablets in the private sector. Nevertheless, all public
sector district health and family welfare centres were provided zinc
tablets free of charge.
Prior to and following the national launch of the scale-up
campaign, training sessions in diarrhea management in line with
the revised WHO/UNICEF guidelines were conducted. These
were tailored for pediatricians, general MBSS physicians, medical
schools, and unregulated providers. For the latter, a 30-min
training video was prepared. ACME drug salesmen provided
verbal information and distributed a specially prepared pamphlet
to private providers.
Because the large majority of parents interviewed identified TV
as their primary source of information, the marketing campaign
focused on this medium, but also prepared messages for radio,
newspapers, billboards, and buses. In rural settings zinc promotion
additionally included the sponsoring of cultural events and
courtyard meetings. Four 30-s TV advertisements were prepared,
the first being a ‘‘teaser’’ and the other three informing listeners of
Baby Zinc treatment of diarrhea. These advertisements were
broadcasted on Bangladesh National Television, which reaches all
parts of Bangladesh. The messages included in the mass media
promotions included awareness of zinc treatment for childhood
diarrhea and its sanctioning by health providers in Bangladesh. All
promotional activities linked zinc treatment to the continued use of
Figure 1. Summary of the cluster sampling framework for the surveys.
doi:10.1371/journal.pmed.1000175.g001
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an additional message to continue the zinc for a full 10 d was
included. Children 6 mo to 5 y of age were targeted.
Survey Interviews
Twelve trained field research assistants divided into two teams
carried out the household interviews and completed a 36 to 40 item
questionnaire, depending upon the survey round (Text S1). Specific
household management practices were documented first, followed
by knowledge questions, including the question ‘‘Prior to this illness
were you aware that zinc can be used to treat diarrhea in your
child?’’ The recommended zinc treatment is 20 mg per day for
10 d, either as a dispersible tablet or 5-cc syrup formulation. In
addition to asking whether zinc was used, we asked for how many
days. Interviewers carried a laminated chart with photos of all syrup
and tablet formulations being sold in Bangladesh to assist
interviewees to identify the product used, In households where the
purchased blister pack or bottle was available, we directly visualized
them to confirm the reported number of days of use. Credit was
given for any zinc formulation given.
Each of the ten selected survey sites required 7–10 d to
complete and each round therefore required 3–4 mo. Timing was
affected by seasonal floods, however the surveys remained on
schedule for the 23 mo of follow-up monitoring. The interviews
addressed the diarrhea illness history, health seeking behaviours,
home management practices, illness-related expenditures, and
sociodemographic characteristics of the households.
Analysis
Data were entered and verified using SPSS-PC version 12.
These files were then converted to STATA-PC version 10.0 for all
analyses. Data files were checked for outliers and reduced
categorical variables were generated. The analyses were stratified
by location of residence into urban (Dhaka city corporation slum
and nonslum districts), municipal, and rural households. To assess
differences in categorical outcomes crude relative risks, 95%
confidence intervals, and chi-square statistical comparisons of
proportions were calculated. Of particular interest was the
identification of disparities in the use of zinc by gender, geographic
location, and income status of the household. Income status was
estimated by determination of a household asset score based upon
ownership of consumer items, dwelling characteristics, toilet
facilities used, and other household characteristics that are related
to wealth status [14,15]. Each asset is assigned a weight generated
through principal components analysis and then standardized
scores assigned. The hypotheses we tested were that significant
(p,0.05) differences in the likelihood of receiving zinc treatment
for childhood diarrhea would be found favouring males, higher
income, and urban nonslum households. Disparities were tested
for significance applying Pearson chi-square statistics. To asses the
magnitude and trends in income disparities, concentration index
curves were determined for each follow-up period [16].
Results
Seven survey rounds were completed with the range in the 2-wk
prevalence (p) of diarrhea and the number of cases (n) surveyed by
location as follows; urban slums p=0.20–0.25 and n=642–646;
urban nonslums p=0.17–0.23 and n=641–658; municipalities
p=0.15–0.19 and n=965–979; rural p=0.19–0.23 and n=962–
976. The mean age of the children at each survey ranged from
26.360.3 mo to 27.460.3 mo and the percentage of cases being
female ranged from 44.2% to 46.6%. Of all cases identified,
98.5% were enrolled in the surveys.
Figure 2 summarizes caretaker awareness of zinc as a treatment
for childhood diarrhea over time stratified by the location of the
household. At baseline, prior to the launch of the mass media
campaign, but following multiple workshops with licensed
pediatricians, awareness was under 5% for all but urban, nonslum
caregivers (99% mothers). In all locations awareness rapidly
increased following the onset of mass media zinc promotion,
reaching peak levels by 10 mo into the campaign. Among the
urban slum and rural populations surveyed, zinc treatment
awareness reached 65% and 55%, respectively, by 23 mo.
As illustrated in Figure 3, the actual use of zinc falls far short of
awareness. With the exception of urban nonslum children, few
received zinc prior to the national mass media launch. By the
second year of the national scale-up campaign approximately 25%
to 30% of urban nonslum, 15% to 20% of urban slum or
Figure 2. Caretaker awareness of zinc treatment for childhood diarrhea before and up to 23 mo following the onset of the mass
media campaign.
doi:10.1371/journal.pmed.1000175.g002
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for their diarrheal illness episode. In urban nonslum and municipal
households the use of zinc levelled off by the end of the first year,
while a steady increase in zinc coverage has been observed in rural
and urban slum areas. Table 1 summarizes the proportion of
children who received zinc stratified by the type of provider seen
during the final, 19- to 23-mo survey round; this is further
subgrouped by whether a tablet or syrup formulation was received.
Children seen by a private, MBBS provider were the most likely to
receive zinc, at nearly 40%. Dispersible zinc tablets accounted for
60% of all zinc purchased.
In each survey period significant differences (p,0.001) in the
use of zinc were observed favouring higher quintile wealth asset
households (Figure 4). At 18 mo significant disparities in the
likelihood of receiving zinc treatment on the basis of gender were
limited to municipal households and favoured males (21% versus
16%, p=0.024). No gender bias at any time interval was observed
in urban slum and rural poor households. As can be seen from the
concentration index curves summarized in Figure 5, income
disparities in the use of zinc decreased over time. Referring to the
figure, if there were no disparity in the use of zinc on the basis of
household income status (asset score) then the poorest 60% of
children would have accounted for 60% of the total zinc
treatments received. At the outset of the mass media campaign
(1–3 mo) this lower 60% accounted for only 28% of the zinc
treatments received, but by the end of the second year (19–23 mo)
this had risen to 46%.
The cross-sectional design of these surveys does not permit a
determination of the number of days the children received zinc
treatment. As a proxy for duration of treatment, caretakers were
Figure 3. The proportion of children receiving zinc treatment by location of household before and up to 23 mo following the onset
of the mass media campaign.
doi:10.1371/journal.pmed.1000175.g003
Table 1. The proportion of children receiving zinc treatment and among these children the formulation taken by type of provider
seen at 19–23 mo post-launch of the scale-up campaign.
Provider Child Formulation Taken
n Children Seen Received Zinc (%) Tablet (%) Syrup (%)
Private, unlicensed village doctors or drug vendors 1,670 18.1 73.5 26.5
Private, licensed MBBS doctors 372 39.2 43.2 56.8
Public sector, MOHFW health providers 220 25.9 49.1 50.9
Overall 2,262 20.3 60.9 39.1
72% of the children surveyed were seen by a provider for their diarrheal illness.
doi:10.1371/journal.pmed.1000175.t001
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to 23 mo following the launch of the mass media campaign in
each of the population strata nearly 50% or more of zinc tablet
purchases were for ,8d .
Figure 7 summarizes changes in the use of ORS during the zinc
scale-up campaign by household location. Variations in the
estimated proportion of children receiving ORS occurred within
each of the population strata over time, but no significant trend,
upwards or downwards, in the use of ORS was observed. There
was no significant change documented in the use of antidiarrheals.
A significant reduction over the 2 y of follow-up in the use of
antibiotics from 34.7% to 27.6% (p,0.001),was observed among
urban nonslum households, but not in the other populations
surveyed.
Discussion
This 2-y follow-up monitoring of the national campaign to scale
up zinc treatment of childhood diarrhea in Bangladesh has
resulted in several observations of relevance to future scale-up
efforts. This campaign largely focused on the promotion of zinc
treatment among private sector providers, but with the strong
support of the public health sector. The TV and radio promotion
of zinc treatment through an electronic mass media campaign was
able to rapidly attain high levels of awareness throughout the
country. Progress in the actual use of zinc has been slower, with
the early adoption primarily observed among urban, higher
income households. Among rural and urban slum households,
whose children stand to benefit the most from zinc, zinc treatment
coverage steadily increased over time and the magnitude of
disparity based upon income status was observed to have been
reduced. Importantly, the scale-up campaign has not negatively
impacted the use of ORS. An important, unmet challenge has
been the failure to adhere to a 10-d course of treatment as
evidenced by the fact over 50% of caregivers were sold seven or
fewer days of zinc treatment.
A potential source of bias and limitation of this study is the
populations surveyed, which may not be representative of hard to
reach, more remote sites in Bangladesh. These sites were chosen
because ICDDR,B researchers were known in these communities,
support structures were in place, and local approval to conduct the
surveys could be more rapidly obtained. The purpose of these
surveys was to document trends in the use of zinc and changes in
other practices within the stratified populations described. The
findings may not, with confidence, be extrapolated to accurately
estimate zinc coverage in all districts of Bangladesh. The sites
chosen within each population strata are, nevertheless, typical
Bangladeshi communities and we are confident that the observed
trends in zinc coverage and reductions in disparities are indicative
of what is occurring in Bangladesh as a whole. Bias in estimates of
zinc treatment awareness may also have been introduced by
repeatedly surveying in the same subdistricts. Those caretakers
interviewed may have discussed the experience with relatives or
neighbours, including the mention of zinc treatment. Households
with a repeated case of diarrhea were not replaced because it was
concluded their exclusion would lead to a biased selection of
healthier children in subsequent surveys. The sites surveyed
contain an estimated population of nearly 1.5 million children
under 5 y of age. This was felt to be a large enough population
base to minimize biased estimates of zinc awareness and would not
have affected zinc coverage estimates. A strength of the surveys
was the selection of households where a child had an active or
recent diarrhea episode of at least 2-d duration. This eliminated
transient, less important episodes and responses were based upon
actual practices.
Promotion among health providers followed two strategies: half-
day diarrhea training workshops and product promotion by drug
salesmen. There are estimated to be over 200,000 health providers
in Bangladesh, thus the challenge of reaching them all through
workshops is not realistic. We therefore placed an early emphasis
on sensitizing and training recognized leaders, such as pediatri-
cians and educators. Less well-trained providers tend to look up to
pediatricians and copy their practices. Among the unlicensed
providers a training of trainers approach was used. While this set
of surveys cannot document the proportion reached, it is likely the
majority of health providers remain poorly informed about zinc
treatment. Reliance on drug salesmen also has limitations. These
Figure 4. Changes in zinc coverage over time by household wealth asset quintile (1 lowest, 5 highest).
doi:10.1371/journal.pmed.1000175.g004
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oriented and based upon prescription medications. Zinc is cheap
and it is an over-the-counter product. Not surprisingly, drug
salesmen will be more inclined to promote higher priced products.
Promotion and distribution of zinc through alternative systems, for
example bottled water distribution networks, would reach a far
greater number of outlets and increase its availability within rural
or urban communities,
Rogers’ diffusion of innovation theory is useful for understand-
ing progress with scaling up health interventions in the general
population over time. The theory describes the adoption of new
innovations as passing through five stages of decision making—
awareness, interest, evaluation, trial, and adoption [17]. At any
stage a consumer, in our case providers or caretakers, can choose
to reject the innovation. The mass media campaign was able to
achieve high levels of awareness and probably interest among all
segments of the Bangladeshi population. Where it has fallen short
is in the transition from awareness to practice (trial and adoption).
This gap highlights an important limitation of electronic media,
which does not benefit from interpersonal communication, thus
showing the need to link mass media messages with personal
messages coming from health providers or other influential
members of a community. The content of the initial commercials
aired in this campaign repeatedly focused on awareness and health
provider sanctioning of zinc treatment and not on household
decision making. Towards the end of the second year of the
campaign the media messages were altered to encourage
household level decision making and enhancing self-efficacy to
try zinc [18]. This strategy and interpersonal communication with
early adopters of zinc treatment are expected to further increase
coverage. The choice of electronic media in this scale-up
campaign was, in part, based on its on its previous success in
promoting the use of oral rehydration therapies (ORT) [19].
Nonetheless, ORTs and zinc share several characteristics that
make them amenable to scaling up through mass media
promotion. Both are fairly simple interventions that are easily
Figure 5. Income disparities in receiving zinc treatment as measured by concentration index curves 1–3 mo and 19–23 mo following
theonset of themass media campaign. Distribution of use of zinc is equal amongincome levels if the concentrationcurve coincides with diagonal.
During the1–3 month interval the 60% of poorest householdsaccounted for 28%of the zinc treatments received,while from 19–23 mo they accounted
for 46%.
doi:10.1371/journal.pmed.1000175.g005
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inexpensive and within the range of typical household diarrheal
illness expenditures among Bangladeshi households [13].
Early adopters of new innovations are known to be better
educated, of higher income status, and have greater access to mass
media [17,20]. We were able to monitor adoption of zinc
treatment by household wealth asset quintiles. Throughout the
2 y of follow up children from higher wealth asset households were
more likely to receive zinc treatment. At the outset of the
campaign children in the highest quintile, when compared to the
Figure 6. Number of zinc tablets purchased by caregivers during the final survey interval 19–23 mo following the mass media
launch.
doi:10.1371/journal.pmed.1000175.g006
Figure 7. ORS utilization prior to and over the first 23 mo of the mass media zinc scale-up campaign.
doi:10.1371/journal.pmed.1000175.g007
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zinc. At the end of the second year this disparity had been reduced
to less than three times as likely. This reduction in income
disparity is further illustrated by the change in the concentration
index curves from the beginning to the end of the follow-up
monitoring.
Given the preventive effects of zinc are likely to require 8–10 d
of treatment, the observation that over half of the children are
receiving less than the required amount remains an important,
unmet challenge. The mass media messages did include a parent
directed reminder to give zinc for 10 d. Unfortunately, in
Bangladesh drug vendors commonly sell antibiotics and other
curative medications to cover only a few days. If a child remains ill,
they return to purchase additional, often alternative, medication.
Parents have little or no experience with continuing medications
once their child appears to be cured. This behavioural change
challenge currently lacks adequate scientific guidance.
All mass media messages in this campaign linked zinc to the use
of oral saline. This connection is important, because zinc is an
adjunct to and not a replacement for oral saline or other approved
rehydration therapies. Future studies need to clarify whether
linking zinc to oral saline may lead to caregiver misunderstanding,
given they are instructed to discontinue the latter once the
diarrhea subsides. Adherence would also be improved if it could be
demonstrated that shorter duration zinc treatment schedules have
equivalent clinical efficacies.
In summary, the national scale up of zinc treatment for
childhood diarrhea in Bangladesh, the first national campaign to
be undertaken, has met with modest success over the initial 2 y of
promotion and has not had a detrimental effect on the use of
ORT. While the relative benefits of provider versus caretaker mass
media–focused promotion cannot be separated in this study, it is
concluded that both strategies are important to undertake. To
improve upon the overall coverage attained of about 20% of
childhood diarrhea episodes will require greater, more consistent
support from health providers and strengthened demand for zinc
treatment from caregivers. Both of these objectives would benefit
from an improved understanding of health system constraints as
well as societal, household, and provider characteristics facilitating
sustained behavioural change leading to the successful scale up of
zinc and other life-saving interventions.
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Background. Diarrheal disease is a significant global health
problem with approximately 4 billion cases and 2.5 million
deaths annually. The overwhelming majority of cases are in
developing countries where there is a particularly high death
rate among children under five years of age. Diarrhea is
caused by bacterial, parasitic, or viral pathogens, which often
spread in contaminated water. Poor hygiene and sanitation,
malnutrition, and lack of medical care all contribute to the
burden of this disease. Replacing lost fluids and salts is a
cheap and effective method to rehydrate people following
dehydration caused by diarrhea. Clinical trials show that zinc,
as part of a treatment for childhood diarrhea, not only helps
to reduce the severity and duration of diarrhea but also
reduces the likelihood of a repeat episode in the future. Zinc
is now included in the guidelines by the World Health
Organization (WHO)/UNICEF for treatment of childhood
diarrhea.
Why Was This Study Done? Zinc treatment together with
traditional oral rehydration salts therapy following episodes
of diarrhea could potentially benefit millions of children in
areas where diarrheal disease is prevalent. The ‘‘Scaling Up of
Zinc for Young Children’’ (SUZY) project was established in
2003 to provide zinc treatment for diarrhea in all children
under five years of age in Bangladesh. The project was
supported by a partnership of public, private,
nongovernmental organization, and multinational sector
agencies during its scale up to a national campaign across
Bangladesh. The partners helped to develop the scale-up
campaign, produce and distribute zinc tablets, train health
professionals to provide zinc treatment, and create media
campaigns (such as advertisements in TV, radio, and
newspapers) to raise awareness and promote the use of
zinc for diarrhea. The researchers wanted to monitor how
effective and successful the national campaign was at
promoting zinc treatment for childhood diarrhea. Also,
they wanted to highlight any potential problems during
the implementation of health care initiatives in areas with
deprived health systems.
What Did the Researchers Do and Find? The researchers
set up survey sites to monitor results from the first two years
of the SUZY campaign. Four areas, each representing
different segments of the population across Bangladesh
were surveyed; urban slums, urban nonslums, municipal
(small city), and rural. There are approximately 1.5 million
children under the age of five across these sites. Households
in each survey site were selected at random, and seven
surveys were conducted at each site between September
2006 and October 2008—about 3,200 children with diarrhea
for each survey. Over 90% of parents used private sector
providers of drug treatment so the campaign focused on
distribution of zinc tablets in the private sector. They were
also available free of charge in the public health sector. TV
and radio campaigns for zinc treatment rapidly raised
awareness across Bangladesh. Awareness was less than
10% in all communities prelaunch and peaked 10 months
later at 90%, 74%, 66%, and 50% in urban nonslum,
municipal, urban slum, and rural sites, respectively.
However, after 23 months only 25% of urban nonslum,
20% of municipal and urban slum, and 10% of rural children
under five years of age were actually using zinc for childhood
diarrhea. Use of zinc was shown to be safe, with few side-
effects, and did not affect the use of traditional treatments
for diarrhea. Researchers also found that many children were
not given the correct ten-day course of treatment; 50% of
parents were sold seven or fewer zinc tablets.
What Do These Findings Mean? These findings show
that the first national campaign promoting zinc treatment
for childhood diarrhea in Bangladesh has had some success.
Addition of zinc tablets for diarrhea treatment did not
interfere with existing therapies. Mass media campaigns,
using TV and radio, were useful for promoting health care
initiatives nationwide alongside the education of health care
providers and care-givers. The study also identified areas
where more work is needed. Surveys in more remote, hard to
reach sites in Bangladesh would provide better
representation of the country as a whole. High awareness
of zinc did not translate into high use. Repeated surveying in
the same subdistricts may have overestimated actual
awareness levels. Furthermore, mass media messages must
link with messages from health care providers to help to
reinforce and promote understanding of the use of zinc. A
change in focus of media messages from awareness to
promoting household decision-making may aid the adoption
of zinc treatment for childhood diarrhea and improve
adherence.
Additional Information Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000175
N The International Centre for Diarrhoeal Disease Research,
Bangladesh Web site has information about the study
N The World Health Organisation provides information on
diarrhea
N The study was sponsored by the Bill & Melinda Gates
Foundation
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